Related Experiment Video

Updated: Jun 4, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

Networking in paediatrics: the example of the Paediatric Rheumatology International Trials Organisation (PRINTO)

Nicolino Ruperto1, Alberto Martini

  • 1Pediatria II, Reumatologia, University of Genoa, EULAR Centre of Excellence in Rheumatology 2008-13, IRCCS G Gaslini, Largo G Gaslini 5, Genoa, Italy.

Archives of Disease in Childhood
|February 15, 2011
PubMed

Insights

International pediatric research networks, like the Pediatric Rheumatology Collaborative Study Group (PRCSG) and Paediatric Rheumatology International Trials Organisation (PRINTO), are crucial for drug safety and efficacy studies in children.

Area of Science:

  • Pediatric Rheumatology
  • Clinical Trials
  • Drug Safety and Efficacy

Background:

  • Implementing pediatric studies faces logistical, methodological, and ethical challenges.
  • New legislation by American and European regulatory agencies promotes pediatric clinical trials.
  • This legislation has initiated advancements in assessing drug safety and efficacy in children.

Purpose of the Study:

  • To highlight the critical role of international pediatric trial networks in implementing new legislation.
  • To showcase the success of these networks in conducting controlled studies on drug safety and efficacy in pediatric rheumatic diseases.
  • To propose these networks as a model for international collaboration in other pediatric subspecialties.

Main Methods:

  • Utilizing established international trial networks: Pediatric Rheumatology Collaborative Study Group (PRCSG) and Paediatric Rheumatology International Trials Organisation (PRINTO).
  • Facilitating controlled studies to evaluate new and existing drugs for pediatric rheumatic diseases.
  • Leveraging legislative support from American and European regulatory agencies.

Main Results:

  • PRCSG and PRINTO have been instrumental in implementing legislation for pediatric clinical trials.
  • These networks have successfully conducted multiple controlled studies on drug safety and efficacy in pediatric rheumatic diseases.
  • The collaborative efforts have advanced the assessment of therapeutic interventions in children.

Conclusions:

  • Networking is essential for overcoming challenges in pediatric research.
  • International trial networks like PRCSG and PRINTO are effective models for pediatric drug development and regulatory compliance.
  • These networks serve as a valuable blueprint for international cooperation in other pediatric subspecialties.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...